Tag: CAR-T

Patient Power 1

CAR T-Cell Therapy Results in Remission for Myeloma Patients

  Mar 03 2021 Tagged CAR-T, MM

In a study posted online by the New England Journal of Medicine, trial leaders report that almost 75% of the participants responded to the therapy, known as idecabtagene vicleucel (ide-cel), and one-third of them had a complete response, or disappearance of all signs of their cancer.

Visit website
Patient Power2

Latest News on CAR T-Cell Therapy for Multiple Myeloma

  Jan 07 2021 Tagged CAR-T, MM

How can CAR T-cell therapy be used to treat multiple myeloma, and what is the latest in CAR T-cell research? Is it getting closer to being an approved treatment option? What are we learning from clinical trials? And finally, what should patients know?

Visit website
Immunotherapy Web Featured Images 72

Multiple Myeloma Roundtable: Immunotherapies & MRD Debate

Each year during the ASH Annual Meeting & Exposition, Patient Power brings together several of the world’s leading experts in multiple myeloma for a roundtable discussion of the latest myeloma research and news. Hear from three renowned experts and Patient Power co-founder Andrew Schorr as they discuss the state of multiple myeloma treatment today including advances in immunotherapy, new promising drug options, the role of minimal residual disease (MRD) testing in determining treatment paths, and other important topics including disparities in multiple myeloma care.

Visit website
Immunotherapy Web Featured Images 67

Comparing CAR-NK and CAR T-Cell Therapies

  Dec 29 2020 Tagged CAR-T, CAR-NK

How Do Chimeric Antigen Receptor (CAR) Therapies Differ? Dr. Katy Rezvani, Chief, Section of Cellular Therapy, Department of Stem Cell Transplantation & Cellular Therapy, MD Anderson Cancer Center joins Patient Power Co-founder Andrew Schorr to explain the difference between the two new cell therapies and what this innovation means for ALL, CLL, and NHL patients.

Visit website
Immunotherapy Web Featured Images 22

How immunotherapy works against cancer (2020 CRI Virtual Immunotherapy Patient S...

  Oct 27 2020 Tagged CAR-T, ICI

Immunotherapy is transforming treatment for many cancers and shows incredible promise for the future of all cancer care. But what is immunotherapy, and how does it work?

Visit website
us news2

Immunotherapy for Blood Cancer

With so many treatments for blood cancer, one option is immunotherapy. Here's what you should know.

Visit website

Understanding Immunotherapy

Visit website

The promise of CAR-T cell therapy

  Feb 18 2020 Tagged CAR-T

Innovative Medicine Initiative (IMI) is a EU public-private partnership funding health research and innovation. Complex therapies like CAR-T cells pose questions no drug developer can answer on their own.

Visit website
ImmunotherapyWebsite Images Featured 15

CAR T-cell therapy: Reprogramming the immune system to treat cancer | Rob Weinko...

At the Malaghan Institute for Biomedical Reserach,researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.

Visit website